Fisher Biosciences unit, Cellomics, and Evotec Technologies Sign License Agreement
Companies to collaborate on cell-biology solutions for life-science markets
01-Feb-2006 -
Cellomics, Inc., a business unit within the Fisher Biosciences group, and Evotec Technologies GmbH announced that they have entered into a worldwide, non-exclusive patent license agreement. The agreement will provide Evotec Technologies with Cellomics' core High Content Screening (HCS) patent ...
biology
cell biology
flow
+6